Cancer patients at UC Irvine Health benefit from an individualized treatment plan tailored to their specific condition. In many cases, this includes chemotherapy following another procedure, such as surgery.
In addition, our oncology team may often recommend a neoadjuvant strategy, in which therapy is given before a primary treatment. For example, radiation or chemotherapy may be used to shrink a tumor before surgery. This may make it possible to perform minimally invasive procedures rather than more invasive ones, reducing trauma and improving patient outcomes.
Our infusion centers in Orange and Costa Mesa provide the most advanced and personalized care to patients undergoing chemotherapy. The infusion center at the UC Irvine Health Cancer Center — Newport, in particular, was designed to provide a tranquil, healing environment.
In addition to conventional treatments, our medical oncologists are also active in clinical testing of novel therapies. These include state-of-the-art drugs and new biological and immunological modifiers being investigated in clinical trials.
Our medical oncologists work closely with UC Irvine Health gynecologic oncologists and colorectal surgeons who perform HIPEC, or hyperthermic intraoperative peritoneal chemotherapy, an advanced treatment for colorectal, gastric, ovarian and other cancers.
As a university medical center, we typically have dozens of clinical trials in progress addressing different conditions, including "refractory" cancers that do not respond to standard treatments. Through participation in clinical trials, patients at UC Irvine Health can gain access to new therapies long before they become available to the general public.
Learn more about our clinical trials ›